Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More 10/31/14 Boston
East Coast Biotech Roundup: PureTech, Celgene, Unum, Biogen & More 10/24/14 Boston
Actavis Nabs Option to Buy Rhythm Pharma’s GI Drug For Diabetics 10/22/14 Boston
East Coast Biotech Roundup: Biogen, Civitas, Rhythm, Alkermes, & More 08/29/14 Boston
East Coast Biotech Roundup: Mergers, Rhythm, Regeneron, & More 05/09/14 Boston
Rhythm Eyes Pivotal Study as GI Drug for Diabetics Hits Phase 2 Mark 05/06/14 Boston
Pfizer Invests in Rhythm to Support Diabetes, Obesity Drug Programs 11/27/12 Boston
Rhythm Pharmaceuticals Obtains $8,000,000 Series B Round 11/27/12 Boston
East Coast Life Sciences Roundup: Pfizer, Rhythm, NPS, More 10/26/12 Boston
Seventh Sense, Polaris, & More Boston Life Sciences Newsmakers 06/15/12 Boston
Rhythm Drums Up $25M to Advance Diabetes and Obesity Drugs 06/13/12 Boston
Boston Deals Span Skill Tests, Mobile Offers, and Cloud Archiving 06/06/12 Boston
Rhythm Pharmaceuticals Secures $25,000,000 Series B Financing Round 06/04/12 Boston
Rhythm Pharmaceuticals Garners $9,500,000 New Financing Round 06/04/12 Boston
AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News 11/11/11 Boston
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News 10/28/11 Boston
MPM-Backed Rhythm Advances Drug Programs in Diabetes and Obesity 10/25/11 Boston
Massachusetts Startups Raise $147M in 25 September Deals; Software Investments Surge 10/25/10 Boston
Dicerna, Actifio Headline Top 10 Third Quarter VC Deals in Massachusetts 10/18/10 Boston
Genzyme Sheds Testing Unit, Red Bend Acquires VirtualLogix, Acceleron Forges Alliance with Shire, & More Boston-Area Deals News 09/15/10 Boston
Pfizer Axes Celldex Agreement, Vertex’s Telaprevir Performs in Clinical Trial, Anchor Therapeutics Inks Potential $480M Deal With J&J, & More Boston-Area Life Sciences News 09/10/10 Boston
Rhythm Boosts Series A Round to $40M, Adds Third Rock Ventures to List of Backers 09/08/10 Boston
Rhythm Pharmaceuticals Garners $19,000,000 Series A Financing 09/08/10 Boston
The Vertex Alumni: Where Are They Now? 04/29/10 Boston
Healthcare Dominates Massachusetts’ Top 10 Deals 04/22/10 Boston
Genetix Gets $35M for Gene Therapy, FDA Delays Decision on Alkermes/Amylin Drug, MedMinder and Vitality Tackle Medication Compliance, & More Boston-Area Life Sciences News 03/19/10 Boston
Sensata and Aveo Go Public; Genetix, Rhythm, and CorrelSense Get Funding; Pegasystems to Acquire Chordiant; & More Boston-Area Deals News 03/17/10 Boston
Rhythm Pharma Gets $21M A Round to Target Obesity, Diabetes 03/15/10 Boston
Rhythm Pharmaceuticals Receives $21,000,000 Series A Funding Round 03/15/10 Boston
Page 1 of 1